首页> 外文OA文献 >SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model

【2h】

SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model

机译：SKLB-287，EGFR和VEGFR2的新型口服多立糖酶抑制剂，在Lovo结直肠肿瘤模型中表现出有效的抗肿瘤活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
X. CHEN; Y. LIU; H.-W. YANG; S. ZHOU; C. CHENG; M.-W. ZHENG; L. ZHONG; X.-Y. FU; Y.-L. PAN; S. MA; Y. TANG; Y.-Z. CHEN; L.-L. LI; S.-Y. YANG;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SKLB-287, A novel oral multikinase inhibitor of EGFR and VEGFR2, Exhibits potent antitumor activity in LoVo colorectal tumor model [J] . ChenX., LiuY., YangH.-W., Neoplasma: Journal of Experimental and Clinical Oncology . 2014,第5期

机译：SKLB-287是一种新型的EGFR和VEGFR2口服多激酶抑制剂，在LoVo大肠肿瘤模型中显示出强大的抗肿瘤活性
2. SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo. [J] . Youli Pan, Yong Xu, Shan Feng, Molecular cancer therapeutics . 2012,第4期

机译：SKLB1206是靶向EGFR激活和T790M突变体ErbB2，ErbB4和VEGFR2的新型口服多激酶抑制剂，在体外和体内均显示出强大的抗肿瘤活性。
3. Potent antitumor activity of cabozantinib, a c- MET and VEGFR2 inhibitor, in a colorectal cancer patient- derived tumor explant model [J] . Song Eun-Kee, Tai W. M., Messersmith Wells A., International Journal of Cancer =: Journal International du Cancer . 2015,第8期

机译：卡博替尼（一种c-MET和VEGFR2抑制剂）在大肠癌患者来源的肿瘤外植体模型中的强抗肿瘤活性
4. KTN0182A, an Anti-KIT, Pyrrolobenzodiazepine (PBD)-Containing Antibody Drug Conjugate (ADC) Demonstrates Potent Antitumor Activity In Vitro and In Vivo Against a Broad Range of Tumor Types [C] . Sergio Trombetta, Christine Lubeski, Gary C. Kemp, PEGS . 2015

机译：KTN0182A，抗试剂盒，吡咯唑二氮杂己酮（PBD）抗体药物缀合物（ADC）在体外和体内抗抗肿瘤类型的抗肿瘤活性
5. Discovery of a small molecule dihydroquinolinone inhibitor with potent antiproliferative and antitumor activity results in catastrophic cell division. [D] . Christadore, Lisa M. 2013

机译：发现具有有效的抗增殖和抗肿瘤活性的小分子二氢喹啉酮抑制剂会导致灾难性的细胞分裂。
6. Potent antitumor activity of Cabozantinib a c-MET and VEGFR2 Inhibitor in a Colorectal Cancer Patient-derived Tumor Explant Model [O] . Eun-Kee Song, WM Tai, Wells A. Messersmith, -1

机译：卡博替尼（一种c-MET和VEGFR2抑制剂）在结直肠癌患者衍生的肿瘤移植模型中的强抗肿瘤活性
7. SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo [O] . Youli Pan, Yong Xu, Shan Feng, 2012

机译：SKLB1206，一种靶向EGFR活化和T790M突变体，ERBB2，ERBB4和VEGFR2的新型口服多立糖酶抑制剂，在体外和体内显示有效的抗肿瘤活性

SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model

著录项

引文网络

相似文献

相关主题

期刊订阅